Decision making with regard to thromboprophylaxis should be based upon the absolute
risks of stroke/thromboembolism and bleeding and the net clinical benefit for a given patient …

Objective To perform a systematic review and meta-analysis of the predictive abilities of
CHADS 2 and CHA 2 DS 2-VASc in stroke and thromboembolism risk stratification of atrial …

Objectives To evaluate the individual risk factors composing the CHADS 2 (Congestive heart
failure, Hypertension, Age≥ 75 years, Diabetes, previous Stroke) score and the CHA 2 DS 2 …

Background: Anticoagulation management of patients with atrial fibrillation (AF) should be
tailored individually on the basis of ischemic stroke risk. The objective of this study was to …

Background: CHADS2 is a simple, validated risk score for predicting the risk for stroke in
patients with atrial fibrillation not treated with anticoagulants. There are sparse data on the …

Atrial fibrillation (AF) is a major cause of stroke and thromboembolism, resulting in
substantial morbidity and mortality. For the majority of patients with AF, aspirin has a limited …

Background—The CHA2DS2-VASc (Congestive heart failure, Hypertension, Age≥ 75
years, Diabetes mellitus, previous Stroke/transient ischemic attack [TIA], Vascular disease …

Stroke Risk Stratification. Introduction: Appropriate stroke risk stratification is essential to
ensure suitable tailoring of antithrombotic therapy. The objective of this study was to assess …

Stroke prevention is central to the management of patients with atrial fibrillation (AF). As
effective stroke prophylaxis essentially requires oral anticoagulants, an understanding of the …

Background Warfarin reduces the risk of stroke in patients with atrial fibrillation (AF) but is
often underused in clinical practice. We aimed to examine the current state of warfarin use in …